LJI and RevolKa will Research Nex-gen Vaccine Antigens by using AI-driven Protein Engineering PlatformTOKYO--(BUSINESS WIRE)--RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech...
Lifetime Achievement Award reflects Jan van Eck and the firm’s leadership and contributions to the ETF industry, from dedication to product innovation to commitment...
Dr. Hayslip to lead development programs for avutometinib, including Verastem Oncology’s international confirmatory Phase 3 RAMP 301 clinical trial, and advance pipeline assetsBOSTON--(BUSINESS WIRE)--Verastem...